Primary human hepatocytes used in this study were obtained from two sources [19] (link): (i) from multiorgan donor HH52 (female; 60 years); the use of liver cells of donor HH52 was approved by “Ethical committee at the Faculty Hospital Olomouc”,and it was in accordance with Transplantation law #285/2002 Sb; “Ethical committee at the Faculty Hospital Olomouc” waived the authors from obtaining consent from the next of kin, regarding human hepatocytes obtained from liver donor HH52. (ii) long-term human hepatocytes in monolayer Batch HEP220770 (female; 35 years), Batch HEP220774 (female; 66 years) were purchased from Biopredic International (Biopredic International, Rennes, France). Cells were cultured in serum-free medium. Cultures were maintained at 37°C and 5% CO2 in a humidified incubator.
Culturing Hepatocellular Carcinoma and Primary Hepatocytes
Primary human hepatocytes used in this study were obtained from two sources [19] (link): (i) from multiorgan donor HH52 (female; 60 years); the use of liver cells of donor HH52 was approved by “Ethical committee at the Faculty Hospital Olomouc”,and it was in accordance with Transplantation law #285/2002 Sb; “Ethical committee at the Faculty Hospital Olomouc” waived the authors from obtaining consent from the next of kin, regarding human hepatocytes obtained from liver donor HH52. (ii) long-term human hepatocytes in monolayer Batch HEP220770 (female; 35 years), Batch HEP220774 (female; 66 years) were purchased from Biopredic International (Biopredic International, Rennes, France). Cells were cultured in serum-free medium. Cultures were maintained at 37°C and 5% CO2 in a humidified incubator.
Corresponding Organization :
Other organizations : Palacký University Olomouc
Variable analysis
- Cell line (HepG2 hepatocellular carcinoma cells vs. primary human hepatocytes)
- Source of primary human hepatocytes (multiorgan donor HH52 vs. Biopredic International batches HEP220770 and HEP220774)
- Not explicitly mentioned
- Culture medium (Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml streptomycin, 100 µg/ml penicillin, 4 mM L-glutamine, 1% non-essential amino acids, and 1 mM sodium pyruvate for HepG2 cells; serum-free medium for primary human hepatocytes)
- Incubation conditions (37°C, 5% CO2, humidified incubator)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!